Sharemaestro Newsreel

WW International, Inc. (NASDAQ:WW) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

WW International (NASDAQ:WW) shares have dropped 30% in the last month, contributing to a 73% loss over the past year, making its 0.1x Price-to-Sales (P/S) ratio seem inexpensive compared to the industry average of 1.6x. However, the company's revenue has been declining, with an …

biote (NASDAQ:BTMD) Posts Quarterly Earnings Results, Misses Estimates By $0.26 EPS

Airsculpt Technologies Inc (AIRS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Airsculpt Technologies Inc (AIRS), detailing analyst ratings, price targets, and expected EPS and revenue figures. The current earnings forecast score for AIRS is 6.67, with an average price target of $6.50. Analysts currently have a "Hold" rating …

WW International (WW) Earnings Date and Reports 2026 $WW

WW International (WW) reported strong Q2 2026 earnings, with an EPS of $1.41, significantly beating analysts' estimates of $0.48. Quarterly revenue also surpassed expectations, coming in at $162.32 million against a consensus of $159.13 million. Despite this beat, the company's EPS is projected to …

Press Release: USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

This press release details USPH's second quarter 2026 financial results, which include revenues of $55.0 million and adjusted EBITDA of $9.0 million. The company also reaffirmed its full-year 2026 guidance, projecting revenues between $215.0 million and $225.0 million and adjusted EBITDA between $37.0 million …

Encompass Health (NYSE:EHC) Exceeds Q2 CY2026 Expectations, Stock Soars

TENET HEALTHCARE CORP SEC Filing (Aug 5, 2026)

This article reports on a TENET HEALTHCARE CORP (THC) SEC Form 144 filing from August 5, 2026. The filing indicates a proposed sale of 600 shares of common stock with an aggregate market value of $157,606.35, acquired through restricted stock vesting on May 23, …

WW International, Inc. (WW) Tops Q2 EPS by 37c; Offers Guidance

WW International, Inc. (NASDAQ: WW) reported strong Q2 earnings, surpassing analyst estimates by $0.37 with an EPS of $1.41. The company's revenue for the quarter was $162.32 million. Furthermore, WW International provided a full-year 2026 revenue outlook of $620 million to $635 million, aligning …

agilon health (NYSE:AGL) Beats Q2 CY2026 Sales Expectations, Full-Year Sales Guidance is Optimistic

Agilon Health (NYSE: AGL) reported stronger-than-expected Q2 CY2026 results, surpassing Wall Street's revenue and profit estimates. The healthcare services company also provided optimistic guidance for the next quarter's revenue and raised its full-year revenue and EBITDA forecasts, indicating positive momentum. Despite historical growth slowdowns, …

The Pennant Group (NASDAQ:PNTG) Delivers Strong Q2 CY2026 Numbers, Full-Year Outlook Slightly Exceeds Expectations

The Pennant Group (NASDAQ:PNTG) reported strong Q2 CY2026 results, exceeding Wall Street's revenue and EPS expectations. The senior living provider saw revenue increase by 37.3% year-on-year to $298 million, with full-year revenue and adjusted EPS guidance also surpassing analyst estimates. Despite strong historical revenue …

WW International Inc. R (WW60.F) Q2 FY2026 earnings call transcript

WW International Inc. (Weight Watchers) reported Q2 FY2026 earnings, highlighting a strategic shift towards higher-value clinical and behavioral tiers. The company saw a 13.9% year-over-year increase in Core+ subscribers and a 30.4% rise in clinical revenue, despite an overall 14.2% drop in total revenue …

AGL Stock Jumps As Wells Fargo Doubles Price Target

agilon health inc. (AGL) stock surged by 15.53% after Wells Fargo more than doubled its price target to $141 from $72, maintaining an Overweight rating. This optimistic outlook is fueled by AGL's strong performance in value-based care, particularly its ACO REACH entities which generated …

DaVita (DVA) Earnings Put Its Valuation Back In Focus

Encompass Health Q2 revenue rises 9.6% as guidance increases

U.S. Physical Therapy integrates 31 clinics; 39 more expected in Q3

Earnings Flash (PNTG) The Pennant Group, Inc. Reports Q2 Revenue $298.0M, vs. FactSet Est of $288.7M

The Pennant Group, Inc. (PNTG) reported second-quarter revenue of $298.0 million, surpassing FactSet's estimate of $288.7 million. The company's diverse operations include home health, hospice, and senior living services across multiple U.S. states. Analysts currently have a "BUY" consensus rating for PNTG, with an …

Earnings Flash (USPH) U.S. Physical Therapy, Inc. Reports Q2 Revenue $214.1M, vs. FactSet Est of $211.4M

U.S. Physical Therapy, Inc. (USPH) announced its Q2 revenue reached $214.1 million, surpassing FactSet's estimated $211.4 million. The company operates 795 outpatient physical therapy clinics and provides industrial injury prevention services across 45 states. This earnings flash follows several recent activities, including a majority …

Earnings Flash (PNTG) The Pennant Group, Inc. Posts Q2 Adjusted EPS $0.36 per Share, vs. FactSet Est of $0.33

The Pennant Group, Inc. (PNTG) reported Q2 adjusted EPS of $0.36 per share, surpassing the FactSet estimate of $0.33. This positive earnings flash also noted the company's Q2 revenue of $298.0 million, which also exceeded the FactSet estimate of $288.7 million. The company has …

Encompass Health expects five hospitals, more than 100 beds by year-end

Encompass Health reports results for second quarter 2026

Brookdale Announces Acquisition of 17 Leased Communities and Refinances All Mortgage Debt Maturities Until 2028

Brookdale Senior Living has entered into an agreement to acquire 17 senior living communities it currently leases for approximately $157 million, adding 735 assisted living and memory care units to its owned portfolio. This acquisition is expected to increase Brookdale's owned portion of consolidated …

WW International (Nasdaq: WW) grows clinical arm as Q2 revenue falls

WW International reported Q2 2026 revenue of $162.3 million, a decrease from Q2 2025, primarily due to a decline in behavioral subscription revenue. However, its higher-priced Clinical offering expanded significantly, with Clinical subscribers growing by 55.7% year-over-year. The company reaffirmed its full-year 2026 guidance …

Concentra Group Holdings Parent, Inc. (NYSE: CON) director sells 130,000 shares

Concentra Group Holdings Parent, Inc. (NYSE: CON) director Robert A. Ortenzio sold 130,000 shares of common stock on August 3, 2026, at a weighted average price of $31.8412 per share. The sale, valued at $4.14 million, was executed indirectly through The Rocco A. Ortenzio …

Truist Financial Maintains AMN Healthcare Services(AMN.US) With Buy Rating

Truist Financial has reiterated its Buy rating on AMN Healthcare Services (AMN.US). The firm also maintained its price target of $105.00 for the company.

[10-Q] agilon health, inc. Quarterly Earnings Report

Agilon Health Inc (AGL) is scheduled to release its Q2 2026 earnings on August 5, 2026, with revenue estimated at $1449.78 million and a loss of $0.75 per share. Analysts have recently increased both revenue and earnings estimates for full-year 2026 and 2027. The …

Pennant Group (NASDAQ: PNTG) details Q2 2026 home health and hospice mix

The Pennant Group (NASDAQ: PNTG) reported strong Q2 2026 results, with revenue increasing to $297,984 thousand and diluted EPS rising to $0.25, driven by growth in both home health and hospice, and senior living segments. The company expanded its operations with six new senior …

Pennant Group (NASDAQ: PNTG) lifts 2026 revenue and EBITDA outlook

The Pennant Group (NASDAQ: PNTG) reported strong second-quarter 2026 results, with total revenue increasing 35.8% year-over-year to $298.0 million and adjusted diluted EPS of $0.36. The company also raised its full-year 2026 guidance for revenue to $1,171.1–$1,190.1 million and adjusted EBITDA to $94.4–$98.0 million, …

Agilon Health tops Q2 estimates, raises 2026 guidance; Shares gain 3%

Agilon Health Inc. (NYSE:AGL) exceeded Q2 analyst expectations and raised its full-year 2026 guidance for total revenues, medical margin, and adjusted EBITDA, leading to a 3.9% rise in shares. The company reported adjusted EPS of $1.04, significantly beating estimates, and revenue increased 7% year-over-year …

Oppenheimer reiterates Compass Pathways stock rating on FDA progress By Investing.com

Oppenheimer has reaffirmed its Outperform rating and $20.00 price target for Compass Pathways (NASDAQ:CMPS) following the company's Q2 2026 update, which bolstered confidence in its psilocybin-based therapy, COMP360. Compass Pathways holds $433 million in cash, providing runway into 2028, and is progressing towards potential …

Compass Pathways (NASDAQ:CMPS) Announces Earnings Results, Misses Expectations By $1.49 EPS

Deutsche Bank Adjusts Pediatrix Medical Price Target to $25 From $19, Maintains Hold Rating

Deutsche Bank has updated its price target for Pediatrix Medical to $25, an increase from the previous target of $19. Despite the raised price target, the firm has decided to maintain its Hold rating on the company's stock. This adjustment reflects an updated valuation …

Empowered Funds LLC Takes $3.08 Million Position in Nutex Health Inc. $NUTX

Empowered Funds LLC has acquired a new stake of 32,451 shares in Nutex Health Inc. (NASDAQ:NUTX), valued at approximately $3.08 million, representing 0.47% of the company. Institutional investors collectively own 5.32% of NUTX, and analysts have a "Moderate Buy" consensus rating with an average …

DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down

DaVita (DVA) reported adjusted earnings of $4.02 per share in Q2 2026, surpassing the Zacks Consensus Estimate, with revenues of $3.55 billion also exceeding expectations. Despite beating earnings and revenue forecasts and seeing an increase in U.S. dialysis treatments, the company's stock fell in …

Earnings call transcript: Ardent Health Q2 2026 EPS misses as stock rises 8%

Ardent Health Services reported Q2 2026 adjusted EPS of $0.12, missing the $0.17 forecast, despite revenue reaching $1.62 billion. The company's stock rose 7.81% in after-hours trading due to strong cash flow, tighter cost control, and reaffirmed full-year guidance. Management highlighted cost cuts and …

COMPASS Pathways Q2 2026 Loss Widens 358.5% Beyond Estimates

COMPASS Pathways plc (NASDAQ:CMPS) reported a Q2 2026 loss of $1.88 per share, significantly wider than the estimated $0.41, representing a 358.5% miss. Despite the substantial net loss of $253.8M, the stock rallied 4.9%, indicating investor focus on clinical development milestones over immediate financial …

Arrowstreet Capital Limited Partnership Acquires New Holdings in InnovAge Holding Corp. $INNV

Arrowstreet Capital Limited Partnership has acquired 417,538 shares of InnovAge Holding Corp. (NASDAQ:INNV) for approximately $3.35 million, representing about 0.31% of the company. Other institutional investors have also increased their stakes in InnovAge, though the stock has received "Sell" ratings from multiple analysts. InnovAge …